Melittin Inhibits Hypoxia-Induced Vasculogenic Mimicry Formation and Epithelial-Mesenchymal Transition through Suppression of HIF-1 α/Akt Pathway in Liver Cancer.

In conclusion, this study indicates melittin may inhibit hypoxia-induced VM formation and EMT in liver cancer through inhibiting HIF-1α/Akt pathway. PMID: 31057657 [PubMed]

https://www.ncbi.nlm.nih.gov/pubmed/31057657?dopt=Abstract

Source: Evidence-based Complementary and Alternative Medicine - May 8, 2019 Category: Complementary Medicine Tags: Evid Based Complement Alternat Med Source Type: research